Overview

Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent Chemotherapy

Status:
Unknown status
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The study includes the recruitment of patients with advanced prostate cancer resistant to chemical castration This is a multicenter prospective trial randomized phase III
Phase:
Phase 3
Details
Lead Sponsor:
University of Turin, Italy
Treatments:
Androgens
Docetaxel